Cohort Study: Assessment of a plasma amyloid probability score to estimate amyloid positron emission tomography findings among adults with cognitive impairment.

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment – JAMA Network Open

Commentary on Twitter

This cohort study found a mass spectrometry-based blood test, measuring plasma Aβ42/40 & ApoE + age, accurately estimated brain amyloidosis via PET, and may help clinicians diagnose Alzheimer disease in patients with symptoms of cognitive impairment. https://t.co/VN7v0qf2uX

— JAMA Network Open (@JAMANetworkOpen) April 21, 2022